Skip to content

EKSO BIONICS HOLDINGS, INC.

CHRN

CIK 0001549084

← back to feed
Revenue (TTM)
$7.35M
Q1 Apr 2026
Net Income (TTM)
−$13.91M
−3.2% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$5.66
+41.8% YoY Q1 Apr 2026
Gross Margin
85.0%
Q1 Apr 2026
Operating Margin
-196.3%
Q1 Apr 2026
Net Margin
-189.1%
Q1 Apr 2026
Free Cash Flow (TTM)
−$11.83M
Q1 Apr 2026
Cash
$3.99M
Q1 Apr 2026
Total Debt
$2M
Q1 Apr 2026
Shares Outstanding
3.56M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings